✦ LIBER ✦

Receptor-mediated radiotherapy with90Y-DOTA-D-Phe1-Tyr3-octreotide

✍ Scribed by Paganelli, Giovanni; Zoboli, Stefania; Cremonesi, Marta; Bodei, Lisa; Ferrari, Mahila; Grana, Chiara; Bartolomei, Mirco; Orsi, Franco; De Cicco, Concetta; Mäcke, Helmut R.

Book ID: 113026408
Publisher: Springer
Year: 2001
Tongue: English
Weight: 193 KB
Volume: 28
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s002590100490

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

52 - D-lysine for reduction of renal[in-

52 - D-lysine for reduction of renal[in-111-DTPA,D-phe-1 ]-octreotide and [Y-90-DOTA,D-phe-1,tyr-3]octreotide uptake

✍ Marion de Jong; Bert Bemard; Wount Breeman; Willem Bakker; Theo Visser; Helmut M 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Receptor radionuclide therapy with90Y-[D

Receptor radionuclide therapy with90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

✍ Lisa Bodei; Marta Cremonesi; Chiara Grana; Paola Rocca; Mirco Bartolomei; Marco 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 247 KB

90Y–DOTA–D-Phe1–Try3– octreotide in ther

90Y–DOTA–D-Phe1–Try3– octreotide in therapy of neuroendocrine malignancies

✍ G. Paganelli; L. Bodei; D. Handkiewicz Junak; P. Rocca; S. Papi; M. Lopera Sierr 📂 Article 📅 2002 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Exceptional Results in Neuroendocrine-Me

Exceptional Results in Neuroendocrine-Metastases-Caused Paraplegia Treated with [90Y-DOTA]-d -Phe1-Tyr3-octreotide (90Y-DOTATOC), a Radiolabelled Somatostatin Analogue

✍ C. Waldherr; A. Haldemann; H.R. Maecke; A. Crazzolara; J. Mueller-Brand 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Evaluation of64Cu-labeled DOTA-d-Phe1-Ty

Evaluation of64Cu-labeled DOTA-d-Phe1-Tyr3-octreotide (64Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors

✍ Hirofumi Hanaoka; Hideyuki Tominaga; Keiich Yamada; Pramila Paudyal; Yasuhiko Ii 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 467 KB

Biokinetics and dosimetry in patients ad

Biokinetics and dosimetry in patients administered with111In-DOTA-Tyr3-octreotide: implications for internal radiotherapy with90Y-DOTATOC

✍ Marta Cremonesi; Mahila Ferrari; Stefania Zoboli; Marco Chinol; Michael G. Stabi 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 426 KB